Pheochromocytoma
Open accessAbstract
Pheochromocytoma, a relatively rare (<0.05% of hypertensives), catecholamine-secreting tumor, is almost always lethal unless recognized and appropriately treated. Clinical and biochemical manifestations are mainly caused by excess circulating catecholamines and hypertension. Manifestations mimic many conditions, which may result in erroneous diagnoses and improper treatment. Sustained or paroxysmal hypertension associated with headaches, sweating, or palpitations, occurs in 95% of patients, but at least 5% are normotensive. All patients with manifestations of hypercatecholaminemia or coexisting neoplasms should be investigated for pheochromocytoma. Plasma free metanephrines and fractionated urinary metanephrines are the most sensitive (about 100%) chemical tests for diagnosing sporadic and familial pheochromocytomas; plasma and urinary catecholamines and total metanephrines are fairly sensitive for identifying sporadic cases but are less sensitive for familial tumors. The clonidine suppression test helps exclude other conditions that may elevate plasma and urinary catecholamines and their metabolites. Magnetic resonance imaging is more sensitive than computed tomography for localizing pheochromocytomas; iodine-131-metaiodobenzylguanidine (131I-MIBG) tumor uptake confers specificity. Surgical resection is successful in 90% of cases, but 10% of tumors are malignant. Pheochromocytomas <5 cm in diameter can be removed laparoscopically; larger tumors should be removed by open surgery. Drug treatment prior to and during surgery is mandatory; drug treatment, chemotherapy, and radiation therapy are used to treat malignant lesions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hypertension is a common sign of pheochromocytoma, but 5% to 15% of patients may have normal blood pressure at presentation, particularly those with incidentaloma or familial screening.
“Hypertension is a common sign of pheochromocytoma, but 5% to 15% of patients may have normal blood pressure at presentation, particularly in those with incidentaloma or having familial screening where the tumor may be smaller and less functionally active at presentation (190).”
From Adrenal incidentaloma (2020) · cites this paper as [190]
Headache occurs in up to 90% of symptomatic patients with pheochromocytoma, with sweating in 60% to 70%.
“Headache occurs in up to 90% of symptomatic patients (190) with sweating in 60% to 70%.”
From Adrenal incidentaloma (2020) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907 · see citing works
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618 · see citing works
Scintigraphic Localization of Pheochromocytoma
Sisson, J. C., Frager, M. S., Valk, T. W., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050103 · Cited by 547 · see citing works
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H. P. H., Berger, D. P., Sigmund, G., Blum, U. C. H., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 463 · see citing works
Extra-Adrenal Pheochromocytoma
Whalen, R. K., Althausen, A. F., & Daniels, G. H. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37119-7 · Cited by 459 · see citing works
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.
Sutton, M. G. S. J., Sheps, S. G., & Lie, J. T. (1981) · PubMed · Cited by 453 · see citing works
Averbuch, S. D., Steakley, C. S., Young, R. C., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427 · see citing works
A Survey on Adrenal Incidentaloma in Italy1
Mantero, F., Terzolo, M., Arnaldi, G., Osella, G., Masini, A. M., Alı̀, A., Giovagnetti, M., Opocher, G., & Angeli, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6372 · Cited by 278 · see citing works
Janetschek, G., FINKENSTEDT, G., Rw, G., et al. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62886-6 · Cited by 262 · see citing works
[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
van der Harst, E., de Herder, W. W., Bruining, H. A., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7238 · Cited by 253 · see citing works
Bravo, E. L., Tarazi, R. C., Fouad, F. M., Vidt, D. G., & Gifford, R. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051107 · Cited by 252 · see citing works
Self-citationCurrent Therapy in Endocrinology and Metabolism
Bardin, C. W. (1985) · Cited by 243 · see citing works
Prevalence of Clinically Unsuspected Pheochromocytoma. Review of a 50-Year Autopsy Series
Sutton, M. G. S. J., Sheps, S. G., & Lie, J. T. (1982) · The Journal of Urology · doi:10.1016/s0022-5347(17)53807-0 · Cited by 240 · see citing works
Sasaki, M., Naomi, S., & Iwaoka, T. (1997) · PubMed · Cited by 229 · see citing works
Pancreatic lesions in the von Hippel-Lindau syndrome
Neumann, H. P. H., Dinkel, E., Brambs, H., et al. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90026-h · Cited by 215 · see citing works
Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma
Raber, W., Raffesberg, W., Bischof, M. G., Scheuba, C., Niederle, B., Gasic, S., Waldhäusl, W. K., & Roden, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2957 · Cited by 180 · see citing works
Clinical and Experimental Pheochromocytoma
Messerli, F. H. (1997) · JAMA · doi:10.1001/jama.1997.03550010092050 · Cited by 154 · see citing works
Jalil, N. D., Pattou, F. N., Combemale, F., Chapuis, Y., Henry, J., Peix, J., & Proye, C. A. G. (2002) · The European Journal of Surgery · doi:10.1080/110241598750004913 · Cited by 150 · see citing works
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi, F. A., Shapiro, B., Fig, L. M., et al. (1989) · PubMed · Cited by 141 · see citing works
Perioperative management of 63 patients with pheochromocytoma
Boutros, A. R., Bravo, E. L., Zanettin, G., et al. (1990) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.57.7.613 · Cited by 135 · see citing works
[123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas
van der Harst, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.685 · Cited by 131 · see citing works
Pheochromocytoma Multisystem Crisis
Newell, K. A. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400320042007 · Cited by 109 · see citing works
Neumann, H. P. H., Reincke, M., Bender, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5872 · Cited by 102 · see citing works
Pheochromocytoma presenting as shock
Bergland, B. E. (1989) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(89)90084-3 · Cited by 94 · see citing works
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
NGUYEN, L. T. H., Niccoli‐Sire, P., Caron, P. J., et al. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440037 · Cited by 85 · see citing works
MR Imaging of Pheochromocytomas
Fink, I. J., Reinig, J. W., Dwyer, A. J., et al. (1985) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198505000-00006 · Cited by 84 · see citing works
EXPERIENCE WITH RETROPERITONEAL LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA
Salomon, L., Rabii, R., Soulie, M., et al. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66231-3 · Cited by 83 · see citing works
The Clonidine Suppression Test for Pheochromocytoma
Sjoberg, R. J. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400180061009 · Cited by 77 · see citing works
Jebara, V. A., Sousa‐Uva, M., Farge, A., et al. (1992) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(92)91354-c · Cited by 75 · see citing works
Neumann, H. P. H. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2608 · Cited by 73 · see citing works
Clinical and Experimental Pheochromocytoma
Cryer, P. E. (1997) · The Endocrinologist · doi:10.1097/00019616-199707050-00013 · Cited by 55 · see citing works
Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases.
Baker, M. E., Spritzer, C. E., Blinder, R., et al. (1987) · Radiology · doi:10.1148/radiology.163.3.3575711 · Cited by 44 · see citing works
Intrapericardial pheochromocytoma
Saad, M. F., Frazier, O. H., Hickey, R. C., et al. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91220-2 · Cited by 42 · see citing works
Mullen, J. R., Cartwright, R. C., Tisherman, S. E., et al. (1985) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198510000-00004 · Cited by 32 · see citing works
Phaeochromocytoma removal and postoperative hypoglycaemia
Meeke, R., O'KEEFFE, J. D., & GAFFNEY, J. D. (1985) · Anaesthesia · doi:10.1111/j.1365-2044.1985.tb10608.x · Cited by 24 · see citing works
Cardiac pheochromocytoma involving the left main coronary artery presenting with exertional angina
Stowers, S. A., Gilmore, P. S., Stirling, M. C., et al. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90513-8 · Cited by 24 · see citing works
Diuretic treatment alters clonidine suppression of plasma norepinephrine.
Hui, T., Krakoff, L. R., Felton, K., et al. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.272 · Cited by 23 · see citing works
EXPERIENCE WITH RETROPERITONEAL LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA
Salomon, L., RABII, R., Soulie, M., et al. (2001) · The Journal of Urology · doi:10.1097/00005392-200106000-00007 · Cited by 17 · see citing works
VALUE OF THE CLONIDINE SUPPRESSION TEST IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA
Karlberg, B. E., & Hedman, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb08962.x · Cited by 8 · see citing works
BRAVO, E. L. (1997) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works
Pheochromocytoma and Paraganglioma
Neumann, H. P. H., Young, W. F., & Eng, C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806651 · Cited by 736 · see citing works
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443 · see citing works
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works
“Headache occurs in up to 90% of symptomatic patients (190) with sweating in 60% to 70%.”
BackgroundGorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43 · see citing works
- Authors
- Manger, W. M., & Gifford, R. W.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Manger, William M.
- Venue
- The Journal of Clinical Hypertension
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 4
- Issue
- 1
- Pages
- 62-72
- ISSN
- 1524-6175 (ISSN-L)
- 1751-7176
- PMC
- PMC8099329
- OpenAlex
- W3188240819
- Cited by
- 143
- References
- 40
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 10 · 2023: 10 · 2022: 14 · 2021: 11 · 2020: 6 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Hypertension (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- pheochromocytoma, catecholamine-secreting tumors, hypertension, hypercatecholaminemia, metanephrine, clonidine suppression test, 131I-MIBG scintigraphy, magnetic resonance imaging, laparoscopic resection, malignant pheochromocytoma, familial pheochromocytoma
- MeSH terms
- Adrenal Gland Neoplasms, Algorithms, Diagnosis, Differential, Humans, Hypertension, Pheochromocytoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review